|
1
|
Jiang T, Mao Y, Ma W, Mao Q, You Y, Yang
X, Jiang C, Kang C, Li X, Chen L, et al: CGCG clinical practice
guidelines for the management of adult diffuse gliomas. Cancer
Lett. 375:263–273. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ricard D, Idbaih A, Ducray F, Lahutte M,
Hoang-Xuan K and Delattre JY: Primary brain tumours in adults.
Lancet. 379:1984–1996. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Louis DN, Perry A, Reifenberger G, von
Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD,
Kleihues P and Ellison DW: The 2016 World Health Organization
classification of tumors of the central nervous system: A summary.
Acta Neuropathol. 131:803–820. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stupp R, Brada M, van den Bent MJ, Tonn JC
and Pentheroudakis G: ESMO Guidelines Working Group: High-grade
glioma: ESMO clinical practice guidelines for diagnosis, treatment
and follow-up. Ann Oncol. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Demuth T and Berens ME: Molecular
mechanisms of glioma cell migration and invasion. J Neurooncol.
70:217–228. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yan H, Parsons DW, Jin G, McLendon R,
Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ,
et al: IDH1 and IDH2 mutations in gliomas. N Eng J
Med. 360:765–773. 2009. View Article : Google Scholar
|
|
7
|
Mellai M, Annovazzi L, Senetta R,
Dell'Aglio C, Mazzucco M, Cassoni P and Schiffer D: Diagnostic
revision of 206 adult gliomas (including 40 oligoastrocytomas)
based on ATRX, IDH1/2 and 1p/19q status. J Neurooncol. 131:213–222.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Brandes AA, Franceschi E, Tosoni A,
Benevento F, Scopece L, Mazzocchi V, Bacci A, Agati R, Calbucci F
and Ermani M: Temozolomide concomitant and adjuvant to radiotherapy
in elderly patients with glioblastoma: Correlation with MGMT
promoter methylation status. Cancer. 115:3512–3518. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang J, Su HK, Zhao HF, Chen ZP and To SS:
Progress in the application of molecular biomarkers in gliomas.
Biochem Biophys Res Commun. 465:1–4. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Huse JT and Aldape KD: The evolving role
of molecular markers in the diagnosis and management of diffuse
glioma. Clin Cancer Res. 20:5601–5611. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hong KU, Choi YB, Lee JH, Kim HJ, Kwon HR,
Seong YS, Kim HT, Park J, Bae CD and Hong KM: Transient
phosphorylation of tumor associated microtubule associated protein
(TMAP)/cytoskeleton associated protein 2 (CKAP2) at Thr-596 during
early phases of mitosis. Exp Mol Med. 40:377–386. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Case CM, Sackett DL, Wangsa D, Karpova T,
McNally JG, Ried T and Camps J: CKAP2 ensures chromosomal stability
by maintaining the integrity of microtubule nucleation sites. PLoS
One. 8:e645752013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hong KU, Kim E, Bae CD and Park J:
TMAP/CKAP2 is essential for proper chromosome segregation. Cell
Cycle. 8:314–324. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yoo BH, Kang DS, Park CH, Kang K and Bae
CD: CKAP2 phosphorylation by CDK1/cyclinB1 is crucial for
maintaining centrosome integrity. Exp Mol Med. 49:e3542017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim YW, Eom BW, Kook MC, Kim HS, Kim MK,
Hwang HL, Chandra V, Poojan S, Song Y, Koh JS, et al: Clinical
implications of proliferation activity in T1 or T2 male gastric
cancer patients. Exp Mol Med. 47:e1932015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gao Y, Liu X, Li T, Wei L, Yang A, Lu Y,
Zhang J, Li L, Wang S and Yin F: Cross-validation of genes
potentially associated with overall survival and drug resistance in
ovarian cancer. Oncol Rep. 37:3084–3092. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kim HS, Koh JS, Choi YB, Ro J, Kim HK, Kim
MK, Nam BH, Kim KT, Chandra V, Seol HS, et al: Chromatin CKAP2, a
new proliferation marker, as independent prognostic indicator in
breast cancer. PLoS One. 9:e981602014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Guo QS, Song Y, Hua KQ and Gao SJ:
Involvement of FAK-ERK2 signaling pathway in CKAP2-induced
proliferation and motility in cervical carcinoma cell lines. Sci
Rep. 7:21172017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Viticchie G, Lena AM, Latina A, Formosa A,
Gregersen LH, Lund AH, Bernardini S, Mauriello A, Miano R, Spagnoli
LG, et al: MiR-203 controls proliferation, migration and invasive
potential of prostate cancer cell lines. Cell Cycle. 10:1121–1131.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu G, Lee YC, Cheng CJ, Wu CF, Song JH,
Gallick GE, Yu-Lee LY, Kuang J and Lin SH: RSK promotes prostate
cancer progression in bone through ING3, CKAP2, and PTK6-mediated
cell survival. Mol Cancer Res. 13:348–357. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hayashi T, Ohtsuka M, Okamura D, Seki N,
Kimura F, Shimizu H, Yoshidome H, Kato A, Yoshitomi H, Furukawa K,
et al: Cytoskeleton-associated protein 2 is a potential predictive
marker for risk of early and extensive recurrence of hepatocellular
carcinoma after operative resection. Surgery. 155:114–123. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yan W, Zhang W, You G, Zhang J, Han L, Bao
Z, Wang Y, Liu Y, Jiang C, Kang C, et al: Molecular classification
of gliomas based on whole genome gene expression: A systematic
report of 225 samples from the Chinese Glioma Cooperative Group.
Neuro Oncol. 14:1432–1440. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bao ZS, Chen HM, Yang MY, Zhang CB, Yu K,
Ye WL, Hu BQ, Yan W, Zhang W, Akers J, et al: RNA-seq of 272
gliomas revealed a novel, recurrent PTPRZ1-MET fusion
transcript in secondary glioblastomas. Genome Res. 24:1765–1773.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hänzelmann S, Castelo R and Guinney J:
GSVA: Gene set variation analysis for microarray and RNA-seq data.
BMC Bioinformatics. 14:72013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Asbaghi Y, Thompson LL, Lichtensztejn Z
and McManus KJ: KIF11 silencing and inhibition induces
chromosome instability that may contribute to cancer. Genes
Chromosomes Cancer. 56:668–680. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Parrilla A, Cirillo L, Thomas Y, Gotta M,
Pintard L and Santamaria A: Mitotic entry: The interplay between
Cdk1, Plk1 and Bora. Cell Cycle. 15:3177–3182. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
De Carli E, Wang X and Puget S:
IDH1 and IDH2 mutations in gliomas. N Eng J Med.
360:2248author reply 2249. 2009. View Article : Google Scholar
|
|
29
|
DeAngelis LM: Brain tumors. N Eng J Med.
344:114–123. 2001. View Article : Google Scholar
|
|
30
|
Tsuchihara K, Lapin V, Bakal C, Okada H,
Brown L, Hirota-Tsuchihara M, Zaugg K, Ho A, Itie-Youten A,
Harris-Brandts M, et al: Ckap2 regulates aneuploidy, cell cycling,
and cell death in a p53-dependent manner. Cancer Res. 65:6685–6691.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kikuchi A, Fumoto K and Kimura H: The
Dickkopf1-cytoskeleton-associated protein 4 axis creates a novel
signalling pathway and may represent a molecular target for cancer
therapy. Br J Pharmacol. 174:4651–4665. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Capes-Davis A, Theodosopoulos G, Atkin I,
Drexler HG, Kohara A, MacLeod RAF, Masters JR, Nakamura Y, Reid YA,
Reddel RR and Freshney RI: Check your cultures! A list of
cross-contaminated or misidentified cell lines. Int J Cancer.
127:1–8. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Allen M, Bjerke M, Edlund H, Nelander S
and Westermark B: Origin of the U87MG glioma cell line: Good news
and bad news. Sci Transl Med. 8:354re3532016. View Article : Google Scholar
|
|
34
|
Li H, Chen L, Li JJ, Zhou Q, Huang A, Liu
WW, Wang K, Gao L, Qi S and Lu YT: miR-519a enhances
chemosensitivity and promotes autophagy in glioblastoma by
targeting STAT3/Bcl2 signaling pathway. J Hematol Oncol. 11:702018.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jantas D, Grygier B, Golda S, Chwastek J,
Zatorska J and Tertil M: An endogenous and ectopic expression of
metabotropic glutamate receptor 8 (mGluR8) inhibits proliferation
and increases chemosensitivity of human neuroblastoma and glioma
cells. Cancer Lett. 432:1–16. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Guo B, Sheng Z, Hu D, Li A, Xu S,
Manghnani PN, Liu C, Guo L, Zheng H and Liu B: Molecular
engineering of conjugated polymers for biocompatible organic
nanoparticles with highly efficient photoacoustic and photothermal
performance in cancer theranostics. ACS Nano. 11:10124–10134. 2017.
View Article : Google Scholar : PubMed/NCBI
|
